Dr. Timothy Burns | Contributors


'Mixed Bag': Only a Fraction of Recent Drug Approvals in NSCLC Space 'Considered Practice Changing'

July 10, 2020

The recent surge of drug approvals in the non-small cell lung cancer (NSCLC) space by the Food and Drug Administration (FDA) is quite unusual and only a fraction of them are considered practice changing, according to Dr. Timothy Burns.